Aastrom Biosciences, Inc. (ASTM) Reports First Quarter 2012 Financial Results  
5/11/2012 10:18:44 AM

ANN ARBOR, Mich., May 10, 2012 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, today reported financial results for the first quarter ended March 31, 2012.